Search Results 901-910 of 19124 for creatinine

1. Blood Brain Barrier Differences In Patients With Brain Tumors Undergoing Surgery - Mayo Clinic

   Creatinine (eGFR ≥ 30). Exclusion Criteria: Vulnerable populations: pregnant women, prisoners, mentally handicapped. Unable to undergo a biopsy of CNS ...

2. Ibrutinib, Lenalidomide, And Dexamethasone In Treating Patients With Multiple Myeloma Ineligible For Transplant - Mayo Clinic

   Calculated or measured creatinine clearance >= 30 ml/min; Total bilirubin =< 1.5 x upper limit of normal (ULN) unless due to Gilbert's syndrome; Aspartate ...

3. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   ... creatinine (sCr), platelet count, international normalized ratio (INR) and total bilirubin 7. History of liver transplantation. Note: Other protocol defined ...

4. Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome - Mayo Clinic

   Creatinine =< 2 x upper limit of normal (ULN); Either serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) or serum glutamic ...

5. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

   Screening serum creatinine > 1.5 mg/dl and eGFR < 60 mL/min/1.73 m2,; Significant renal disease, including nephritic syndrome, chronic kidney disease ...

6. Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) - Mayo Clinic

   * Treatment with any serum creatinine-altering drugs within 1 month prior to screening Visit 1 including but not limited to amphotericin, cimetidine ...

7. A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients - Mayo Clinic

   Creatinine clearance (CrCl) >= 30 milliliter per minute (mL/min); Plan to initiate systemic cancer therapy within plus or minus (+-) 1 week of receiving the ...

8. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma - Mayo Clinic

   Creatinine no greater than 1.8 mg/dL. Cardiovascular: No history of active ischemic heart disease; No cerebrovascular disease; No congestive heart failure (New ...

9. CraniSeal Post Approval Study - Mayo Clinic

   * Patient with diagnosis of severely altered renal (creatinine levels \> 2.0 mg/dL) or hepatic (total bilirubin \> 2.5 mg/dL) function. * Patient diagnosed ...

10. A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites - Mayo Clinic

    Serum creatinine > 1.5 mg/dl; Serum bilirubin > 5 mg/dl; eGFR < 30 ml/min/1.73m2 by MDRD (Modification of Diet in Renal Disease) method; Gastrointestinal ...